Scientists have identified a crucial “target” for drug treatments that could potentially halt the progression of pancreatic cancer, offering renewed hope for patients. Experts suggest this breakthrough could lead to significantly improved outcomes for those diagnosed with the disease.
Pancreatic cancer remains a devastating diagnosis in the UK, affecting almost 11,000 people annually.
